The clinical role of VeriStrat testing in patients with advanced non–small cell lung cancer considered unfit for first-line platinum-based chemotherapy

Lee, S.M., Upadhyay, S., Lewanski, C. et al. (11 more authors) (2019) The clinical role of VeriStrat testing in patients with advanced non–small cell lung cancer considered unfit for first-line platinum-based chemotherapy. European Journal of Cancer, 120. pp. 86-96. ISSN 0959-8049

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Non-small cell lung cancer; Biomarker; Prognostic; Predictive; VeriStrat; Proteonomic; Poor performance ECOG 2&3; Active supportive care
Dates:
  • Accepted: 29 July 2019
  • Published (online): 6 September 2019
  • Published: October 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Human Metabolism (Sheffield)
The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 03 Feb 2020 16:13
Last Modified: 03 Feb 2020 16:17
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.ejca.2019.07.025
Related URLs:

Export

Statistics